Mythocondro has reached the unio List of Novel Foods in accordance with the Novel Food Regulation (EU) 2015/2283 and the subsequent Commission Implementing Regulation (EU) 2017/2470 issued on December 20, 2017, after having obtained the Novel Food authorization by the Minister for Medical Care in the Netherlands.

This is the first success of 2018 for Gnosis, which is now authorized to sell Mythocondro to European companies, thus contributing to the diffusion of an innovative non-animal and high-quality Chondroitin Sulfate.

Mythocondro, unlike common CS sold in the market, is not made from extracts of animal tissues and therefore, further to be suitable for vegetarians, vegans and people with dietary restrictions related to their religion.

 
It also solves any concern related to the production origin, the possible presence of transmissible infective agents, contaminations and adulterations, typical of animal-derived raw materials.

Mythocondro, exclusively produced by Gnosis, is the first bio-fermented Chondroitin Sulfate with a cruelty-free production process.